GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Capha Pharmaceuticals Inc (OTCPK:FPSUF) » Definitions » Debt-to-Equity

Capha Pharmaceuticals (Capha Pharmaceuticals) Debt-to-Equity : -0.96 (As of Sep. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Capha Pharmaceuticals Debt-to-Equity?

Capha Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.34 Mil. Capha Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Capha Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-0.36 Mil. Capha Pharmaceuticals's debt to equity for the quarter that ended in Sep. 2023 was -0.96.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Capha Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

FPSUF' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.04   Med: -0.94   Max: -0.44
Current: -0.96

During the past 13 years, the highest Debt-to-Equity Ratio of Capha Pharmaceuticals was -0.44. The lowest was -1.04. And the median was -0.94.

FPSUF's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs FPSUF: -0.96

Capha Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for Capha Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Capha Pharmaceuticals Debt-to-Equity Chart

Capha Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.83 -0.78 -0.94 -0.96 -0.97

Capha Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.95 -0.97 -0.96 -0.98 -0.96

Competitive Comparison of Capha Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Capha Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Capha Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Capha Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Capha Pharmaceuticals's Debt-to-Equity falls into.



Capha Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Capha Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Capha Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Capha Pharmaceuticals  (OTCPK:FPSUF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Capha Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Capha Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Capha Pharmaceuticals (Capha Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
4205 Gellatly Road, Suite 324, West Kelowna, BC, CAN, V4T 2K2
Capha Pharmaceuticals Inc is a Canada-based company principally operating in the pharmaceutical industry. The company produces and distributes products in Canada and the United States of America.

Capha Pharmaceuticals (Capha Pharmaceuticals) Headlines

No Headlines